Xeris Pharmaceuticals Stock Forecast - Triple Exponential Smoothing

XERS Stock  USD 3.54  0.04  1.12%   
The Triple Exponential Smoothing forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 3.54 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.79. Xeris Stock Forecast is based on your current time horizon.
  
At this time, Xeris Pharmaceuticals' Inventory Turnover is comparatively stable compared to the past year. Receivables Turnover is likely to gain to 5.28 in 2024, whereas Payables Turnover is likely to drop 1.59 in 2024. . Common Stock Shares Outstanding is likely to gain to about 144.6 M in 2024, whereas Net Loss is likely to drop (89.5 M) in 2024.

Open Interest Against 2024-12-20 Xeris Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Xeris Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Xeris Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Xeris Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Xeris Pharmaceuticals' open interest, investors have to compare it to Xeris Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Xeris Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Xeris. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Triple exponential smoothing for Xeris Pharmaceuticals - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Xeris Pharmaceuticals prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Xeris Pharmaceuticals price movement. However, neither of these exponential smoothing models address any seasonality of Xeris Pharmaceuticals.

Xeris Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 12th of December 2024

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 3.54 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.79.
Please note that although there have been many attempts to predict Xeris Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Xeris Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Xeris Pharmaceuticals Stock Forecast Pattern

Backtest Xeris PharmaceuticalsXeris Pharmaceuticals Price PredictionBuy or Sell Advice 

Xeris Pharmaceuticals Forecasted Value

In the context of forecasting Xeris Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Xeris Pharmaceuticals' downside and upside margins for the forecasting period are 0.91 and 6.16, respectively. We have considered Xeris Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.54
3.54
Expected Value
6.16
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Xeris Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Xeris Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0108
MADMean absolute deviation0.0642
MAPEMean absolute percentage error0.0204
SAESum of the absolute errors3.785
As with simple exponential smoothing, in triple exponential smoothing models past Xeris Pharmaceuticals observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Xeris Pharmaceuticals observations.

Predictive Modules for Xeris Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xeris Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.783.406.02
Details
Intrinsic
Valuation
LowRealHigh
1.514.126.75
Details
6 Analysts
Consensus
LowTargetHigh
4.464.905.44
Details

Other Forecasting Options for Xeris Pharmaceuticals

For every potential investor in Xeris, whether a beginner or expert, Xeris Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Xeris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Xeris. Basic forecasting techniques help filter out the noise by identifying Xeris Pharmaceuticals' price trends.

View Xeris Pharmaceuticals Related Equities

 Risk & Return  Correlation

Xeris Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Xeris Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Xeris Pharmaceuticals' current price.

Xeris Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Xeris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xeris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xeris Pharmaceuticals stock market strength indicators, traders can identify Xeris Pharmaceuticals entry and exit signals to maximize returns.

Xeris Pharmaceuticals Risk Indicators

The analysis of Xeris Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Xeris Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xeris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xeris Stock Analysis

When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.